Bridgeway Capital Management’s NantHealth, Inc NH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-18,432
| Closed | -$37K | – | 1498 |
|
|
2023
Q1 | $37K | Hold |
18,432
| – | – | ﹤0.01% | 1334 |
|
|
2022
Q4 | $67.3K | Sell |
18,432
-1
| -0% | -$4 | ﹤0.01% | 1269 |
|
|
2022
Q3 | $68K | Sell |
18,433
-2,000
| -10% | -$14.2K | ﹤0.01% | 1328 |
|
|
2022
Q2 | $128K | Sell |
20,433
-2,734
| -12% | -$25.5K | ﹤0.01% | 1183 |
|
|
2022
Q1 | $262K | Hold |
23,167
| – | – | 0.01% | 1118 |
|
|
2021
Q4 | $367K | Buy |
23,167
+19,834
| +595% | +$420K | 0.01% | 1054 |
|
|
2021
Q3 | $81K | Buy |
+3,333
| New | +$100K | ﹤0.01% | 1260 |
|
|
2020
Q4 | – | Sell |
-2,487
| Closed | -$87K | – | 1385 |
|
|
2020
Q3 | $87K | Hold |
2,487
| – | – | ﹤0.01% | 1265 |
|
|
2020
Q2 | $171K | Sell |
2,487
-12,773
| -84% | -$509K | ﹤0.01% | 1173 |
|
|
2020
Q1 | $364K | Buy |
+15,260
| New | +$365K | 0.01% | 860 |
|
|
2019
Q4 | – | Sell |
-4,060
| Closed | -$44K | – | 1408 |
|
|
2019
Q3 | $44K | Hold |
4,060
| – | – | ﹤0.01% | 1280 |
|
|
2019
Q2 | $32K | Hold |
4,060
| – | – | ﹤0.01% | 1288 |
|
|
2019
Q1 | $56K | Hold |
4,060
| – | – | ﹤0.01% | 1310 |
|
|
2018
Q4 | $33K | Buy |
+4,060
| New | +$71.1K | ﹤0.01% | 1349 |
|
Bridgeway Capital Management's NH Position: Q2 2023 in Review
Bridgeway Capital Management sold out of NantHealth, Inc (NH) in Q2 2023, closing a stake of 18,432 shares — an estimated $37K sold.
Bridgeway Capital Management first reported a position in NH in Q4 2018 and held it in 14 quarters. The position peaked at $367K in Q4 2021. 0 funds tracked by Wall St. Rank hold NH as of Q2 2023.
- Bridgeway Capital Management reported no remaining NantHealth, Inc position as of Q2 2023 after selling out during the quarter.
- Bridgeway Capital Management sold 18,432 NantHealth, Inc shares in Q2 2023, an estimated $37K.
- Bridgeway Capital Management first reported a position in NantHealth, Inc in Q4 2018 and held it in 14 quarters.
- Bridgeway Capital Management's NantHealth, Inc position peaked at $367K in Q4 2021.
- 0 funds tracked by Wall St. Rank held NantHealth, Inc as of Q2 2023.
Based on Bridgeway Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.